Summary of Study ST002329
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001493. The data can be accessed directly via it's Project DOI: 10.21228/M8R403 This work is supported by NIH grant, U2C- DK119886. See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Study ID | ST002329 |
| Study Title | Serum metabonomics of rats in sham, HIE, CO and ASO groups were compared. |
| Study Summary | To study the cerebral protective of nervonic acid after hypoxia-ischemia (HI), rats were randomly divided into two groups: Sham group (n=12), HIE group (n=8). After 48 hours of successful modeling, we re-group the HIE group: CO group (n=5) and ASO group (n=8). The ASO group were treated by Acer truncatum Bunge seed oil for 30 days, rats in the CO group were treated by an equal volume of corn oil. |
| Institute | Bao Feng Key Laboratory of Genetics and Metabolism |
| Last Name | Chen |
| First Name | xianyang |
| Address | Room 525, Floor 5, Building 3, Yard 10, Anxiang Street, Airport Economic Core Zone, Shunyi District, Beijing |
| cxyibcas@163.com | |
| Phone | 13681398052 |
| Submit Date | 2022-10-08 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | mzXML |
| Analysis Type Detail | LC-MS |
| Release Date | 2026-01-02 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR001493 |
| Project DOI: | doi: 10.21228/M8R403 |
| Project Title: | Lipidomic profiling indicate protection of hypoxic-ischemic brain injury on neonatal rats ingesting Acer truncatum Bunge oil |
| Project Summary: | Hypoxic ischemic encephalopathy (HIE) has a great impact on the growth and development of newborns. At present, there is a lack of other effective intervention measures except hypothermia therapy, and the effective rate of hypothermia therapy is less than 50%. Using high-throughput metabonomics, we analyzed the serum and brain tissues of 7-day-old HIE mice, mice fed with Acer truncatum Bunge seed oil (ASO) for 30 days and mice fed with their respective ages. All the results revealed that a variety of metabolites changed significantly during injury and repair, and there were many significant enrichment pathways of designed lipid metabolism and neurotrophic factors. Multi-group comparative analysis identified metabolites that may be related to the injury and repair of hypoxic-ischemic encephalopathy, such as glycerol phospholipids and sphingomyelins. Our results suggest that ASO may be a potential special medical food for ischemic hypoxia newborns. |
| Institute: | Bao Feng Key Laboratory of Genetics and Metabolism |
| Last Name: | Chen |
| First Name: | xianyang |
| Address: | Room 525, Floor 5, Building 3, Yard 10, Anxiang Street, Airport Economic Core Zone, Shunyi District, Beijing |
| Email: | cxyibcas@163.com |
| Phone: | 13681398052 |
Subject:
| Subject ID: | SU002416 |
| Subject Type: | Mammal |
| Subject Species: | Rattus norvegicus |
| Taxonomy ID: | 10116 |
| Species Group: | Mammals |
Factors:
Subject type: Mammal; Subject species: Rattus norvegicus (Factor headings shown in green)
| mb_sample_id | local_sample_id | Group |
|---|---|---|
| SA229575 | 20210626_91 | ASO1 |
| SA229576 | 20210624_91 | ASO1 |
| SA229577 | 20210626_29 | ASO2 |
| SA229578 | 20210624_29 | ASO2 |
| SA229579 | 20210624_56 | ASO3 |
| SA229580 | 20210626_56 | ASO3 |
| SA229581 | 20210626_13 | ASO4 |
| SA229582 | 20210624_13 | ASO4 |
| SA229583 | 20210626_31 | ASO5 |
| SA229584 | 20210624_31 | ASO5 |
| SA229585 | 20210624_44 | ASO6 |
| SA229586 | 20210626_44 | ASO6 |
| SA229587 | 20210626_52 | ASO7 |
| SA229588 | 20210624_52 | ASO7 |
| SA229589 | 20210626_61 | ASO8 |
| SA229590 | 20210624_61 | ASO8 |
| SA229591 | 20210624_41 | CO1 |
| SA229592 | 20210626_41 | CO1 |
| SA229593 | 20210624_49 | CO2 |
| SA229594 | 20210626_49 | CO2 |
| SA229595 | 20210626_36 | CO3 |
| SA229596 | 20210624_36 | CO3 |
| SA229597 | 20210624_24 | CO4 |
| SA229598 | 20210626_24 | CO4 |
| SA229599 | 20210624_68 | CO5 |
| SA229600 | 20210626_68 | CO5 |
| SA229601 | 20210624_12 | HIE1 |
| SA229602 | 20210626_12 | HIE1 |
| SA229603 | 20210624_23 | HIE2 |
| SA229604 | 20210626_23 | HIE2 |
| SA229605 | 20210626_35 | HIE3 |
| SA229606 | 20210624_35 | HIE3 |
| SA229607 | 20210626_47 | HIE4 |
| SA229608 | 20210624_47 | HIE4 |
| SA229609 | 20210624_59 | HIE5 |
| SA229610 | 20210626_59 | HIE5 |
| SA229611 | 20210624_79 | HIE6 |
| SA229612 | 20210626_79 | HIE6 |
| SA229613 | 20210624_63 | HIE7 |
| SA229614 | 20210626_63 | HIE7 |
| SA229615 | 20210626_75 | HIE8 |
| SA229616 | 20210624_75 | HIE8 |
| SA229617 | 20210626_64 | sham1 |
| SA229618 | 20210624_64 | sham1 |
| SA229619 | 20210626_45 | sham10 |
| SA229620 | 20210624_45 | sham10 |
| SA229621 | 20210624_43 | sham11 |
| SA229622 | 20210626_43 | sham11 |
| SA229623 | 20210626_55 | sham12 |
| SA229624 | 20210624_55 | sham12 |
| SA229625 | 20210624_32 | sham2 |
| SA229626 | 20210626_32 | sham2 |
| SA229627 | 20210626_18 | sham3 |
| SA229628 | 20210624_18 | sham3 |
| SA229629 | 20210626_26 | sham4 |
| SA229630 | 20210624_26 | sham4 |
| SA229631 | 20210626_78 | sham5 |
| SA229632 | 20210624_78 | sham5 |
| SA229633 | 20210624_80 | sham6 |
| SA229634 | 20210626_80 | sham6 |
| SA229635 | 20210624_15 | sham7 |
| SA229636 | 20210626_15 | sham7 |
| SA229637 | 20210626_60 | sham8 |
| SA229638 | 20210624_60 | sham8 |
| SA229639 | 20210626_28 | sham9 |
| SA229640 | 20210624_28 | sham9 |
| Showing results 1 to 66 of 66 |
Collection:
| Collection ID: | CO002409 |
| Collection Summary: | After sevoflurane inhalation anesthesia, use a blood collection vessel without any additives (without any anticoagulant or accelerator) to collect whole blood. Let it stand at 4 ℃ for about 1h. After the blood coagulates, centrifuge at low speed (3000 rpm, 10 min, 4 ℃), take the upper serum, and centrifuge at high speed (12000 rpm, 10 min, 4 ℃). After centrifugation, take the upper serum and transfer it to a 1.5mL centrifuge tube, 200 μ L Carry out equal subpackaging, make marks, seal with sealing film, and freeze at - 80 ℃. |
| Sample Type: | Blood (serum) |
Treatment:
| Treatment ID: | TR002428 |
| Treatment Summary: | To study the cerebral protective of nervonic acid after hypoxia-ischemia (HI), rats were randomly divided into two groups: Sham group (n=12), HIE group (n=8). After 48 hours of successful modeling, we re-group the HIE group: CO group (n=5) and ASO group (n=8). The ASO group were treated by Acer truncatum Bunge seed oil for 30 days, rats in the CO group were treated by an equal volume of corn oil25. Based on the individual recommended intake NA of 0.3 g/kg/d, the equivalent dose of the drug was calculated according to the bodyweight of the human and the animal, in which the daily dose of the rat was equivalent to six times that of adults. |
Sample Preparation:
| Sampleprep ID: | SP002422 |
| Sampleprep Summary: | We use isopropanol (IPA) to extract lipids from serum and brain tissue. In brief, 200 μL of serum was extracted with 600 μL of precooled IPA temperature of 4°C, vortexed for 1 minute and incubated for 10 minutes at room temperature; the extracted mixture was stored overnight at -20 ° C. Samples were centrifuged for 20 minutes at 14000 rpm, and the supernatants were transferred into a new centrifuge tube and diluted to 1:10 with IPA/ACN/H2O (2.5:1:1, v: v: v). Before LC/MS analysis, the sample was stored at -80°C. |
Combined analysis:
| Analysis ID | AN003799 | AN003800 |
|---|---|---|
| Chromatography ID | CH002811 | CH002811 |
| MS ID | MS003541 | MS003542 |
| Analysis type | MS | MS |
| Chromatography type | Reversed phase | Reversed phase |
| Chromatography system | Waters Acquity I-Class | Waters Acquity I-Class |
| Column | Waters Acquity BEH C18 (100 x 2mm,1.7um) | Waters Acquity BEH C18 (100 x 2mm,1.7um) |
| MS Type | ESI | ESI |
| MS instrument type | QTOF | QTOF |
| MS instrument name | Waters Xevo-G2-XS | Waters Xevo-G2-XS |
| Ion Mode | POSITIVE | NEGATIVE |
| Units | Peak area | Peak area |
Chromatography:
| Chromatography ID: | CH002811 |
| Chromatography Summary: | ACQUITYUPLC I-CLASS (Waters) and XEVO-G2XS quadrupole time-of-flight (QTOF) mass spectrometry (Waters) with ESI were used to analyze the samples. |
| Methods Filename: | Chrom__methods_.pdf |
| Instrument Name: | Waters Acquity I-Class |
| Column Name: | Waters Acquity BEH C18 (100 x 2mm,1.7um) |
| Flow Rate: | 0.4 mL/min |
| Solvent A: | 60% acetonitrile/40% water; 0.1% formic acid; 10 mM ammonium formate |
| Solvent B: | 90% isopropanol/10% acetonitrile; 0.1% formic acid; 10 mM ammonium formate |
| Chromatography Type: | Reversed phase |
MS:
| MS ID: | MS003541 |
| Analysis ID: | AN003799 |
| Instrument Name: | Waters Xevo-G2-XS |
| Instrument Type: | QTOF |
| MS Type: | ESI |
| MS Comments: | - |
| Ion Mode: | POSITIVE |
| MS ID: | MS003542 |
| Analysis ID: | AN003800 |
| Instrument Name: | Waters Xevo-G2-XS |
| Instrument Type: | QTOF |
| MS Type: | ESI |
| MS Comments: | - |
| Ion Mode: | NEGATIVE |